“Evaluation of the CRISPR Cas9 System As Genome Editing Platform for the Mucopolysaccharidosis IV A Using a Strategy for Induction of Higher Homologous Recombination Frequency”. Universitas Scientiarum, vol. 30, Apr. 2025, pp. 82-106, https://doi.org/10.11144/.